Cases & Deals

  • Home
  • Practices
  • Dendreon completes $229.9 million public offering of Common Stock

Share

Dendreon completes $229.9 million public offering of Common Stock

May 2009

Client(s) Dendreon Corporation

Jones Day advised Dendreon Corporation, a biotechnology company focused on the discovery, development and commercialization of therapeutics that improve cancer treatment options for patients, in connection with the $229.9 million public offering of Common Stock, underwritten by Deutsche Bank Securities.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.